A comparison of the inhibition of ovulation achieved by desogestrel 75 μg and levonorgestrel 30 μg daily

被引:80
|
作者
Rice, CF
Killick, SR
Dieben, T
Bennink, HC
机构
[1] Princess Royal Hosp, Dept Obstet & Gynaecol, Hull HU8 9HE, N Humberside, England
[2] NV Organon, Clin Dev Dept, NL-5340 BH Oss, Netherlands
关键词
desogestrel; inhibition of ovulation; levonorgestrel; progestogen-only contraceptives;
D O I
10.1093/humrep/14.4.982
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A randomized, double blind, group comparative study was performed over a 12 month period to compare inhibition of ovulation during the use of two (progestogen-only) oral contraceptives containing doses of 75 mu g desogestrel or 30 mu g levonorgestrel. Seventy-one female volunteers with regular cycles and established ovulation by ultrasonography and serum progesterone concentrations were recruited from an out-patient clinic in a university hospital and asked to participate in the study. Transvaginal ultrasonography and serum oestradiol, progesterone, luteinizing hormone (LH) and follicle stimulating hormone (FSH) measurements were performed throughout the 7th and 12th 28 day treatment period. Desogestrel at a dose of 75 mu g showed a significant inhibition of ovulation compared to 30 mu g levonorgestrel (P < 0.001).
引用
收藏
页码:982 / 985
页数:4
相关论文
共 30 条
  • [1] The effects of two progestogen-only pills containing either desogestrel (75 μg/day) or levonorgestrel (30 μg/day) on lipid metabolism
    Barkfeldt, J
    Virkkunen, A
    Dieben, T
    CONTRACEPTION, 2001, 64 (05) : 295 - 299
  • [2] A randomized controlled double-blind study of the effects on hemostasis of two progestogen-only pills containing 75μg desogestrel or 30μg levonorgestrel
    Winkler, UH
    Howie, H
    Bühler, K
    Korver, T
    Geurts, TBP
    Bennink, HJTC
    CONTRACEPTION, 1998, 57 (06) : 385 - 392
  • [3] The effects of two progestogen-only pills containing either desogestrel (75 μg/day) or levonorgestrel (30 μg/day) on carbohydrate metabolism and adrenal and thyroid function
    Kivelä, A
    Ruuskanen, M
    Ågren, U
    Dieben, T
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2001, 6 (02) : 71 - 77
  • [4] Inhibition of ovulation by an oral contraceptive containing 100 mu g levonorgestrel in combination with 20 mu g ethinylestradiol
    Spona, J
    Feichtinger, W
    Kindermann, C
    Wunsch, C
    Brill, K
    CONTRACEPTION, 1996, 54 (05) : 299 - 304
  • [5] Latin American experience with two low-dose oral contraceptives containing 30 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel
    Bassol, S
    Alvarado, A
    Celis, C
    Cravioto, MC
    Peralta, O
    Montaño, R
    Novelli, J
    Albornoz, H
    Kesseru, E
    Soares, A
    Petracco, A
    Isaia, B
    Mendes, J
    Bahamondes, L
    de Melo, NR
    Reyes-Marquez, R
    Albrecht, G
    CONTRACEPTION, 2000, 62 (03) : 131 - 135
  • [6] Maintenance of ovulation inhibition with the 75-μg desogestrel-only contraceptive pill (Cerazette®) after scheduled 12-h delays in tablet intake
    Korver, T
    Klipping, C
    Heger-Mahn, D
    Duijkers, I
    van Osta, G
    Dieben, T
    CONTRACEPTION, 2005, 71 (01) : 8 - 13
  • [7] A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 μg of ethinylestradiol and 100 μg of levonorgestrel with 30 μg of ethinylestradiol and 100 μg of levonorgestrel
    Jespersen, J
    Endrikat, J
    Düsterberg, B
    Schmidt, W
    Gerlinger, C
    Wessel, J
    Sidelmann, JJ
    Skouby, SO
    CONTRACEPTION, 2005, 72 (02) : 98 - 104
  • [8] Effect of desogestrel 75 μg on headache frequency and intensity in women with migraine: a prospective controlled trial
    Merki-Feld, Gabriele S.
    Imthurn, Bruno
    Gantenbein, Andreas R.
    Sandor, Peter
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2019, 24 (03) : 175 - 181
  • [9] Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 μg/ethinyl estradiol 20 μg
    Johnson, Julia V.
    Grubb, Gary S.
    Constantine, Ginger D.
    CONTRACEPTION, 2007, 75 (01) : 23 - 26
  • [10] Clinical comparative study of oral contraceptives containing 30 μg ethinylestradiol/150 μg levonorgestrel, and 35 μg ethinylestradiol/250 μg norgestimate in Thai women
    Tantbirojn, P
    Taneepanichskul, S
    CONTRACEPTION, 2002, 66 (06) : 401 - 405